Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Sandoz Tries Again With US Pegfilgrastim

Apr 04 2019

• By Dave Wallace

TryAgain — Sandoz Is Making Another Attempt With Its US Pegfilgrastim Biosimilar • Source: Shutterstock

Related Content

Biocon confirms US Neulasta rival launch

Aug 03 2018

Sandoz drops rituximab after US seeks more data

Nov 09 2018

Mylan’s Fulphila has secured an 8% share

Nov 09 2018

Three firms in EU get nods on pegfilgrastim

Nov 30 2018

Coherus Confirms Udenyca Launch And Brings In Chief Medical Officer

Jan 07 2019

Additional Topics

United States Biosimilars Regulation

More from Biosimilars

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window